je.st
news
Home
› SRI International Announces PDCellX Xenograft Tumor Model Services To Accelerate Cancer Drug Research
SRI International Announces PDCellX Xenograft Tumor Model Services To Accelerate Cancer Drug Research
2014-04-30 07:22:26| drugdiscoveryonline News Articles
SRI International has announced the availability of its PDCellX™ xenograft tumor model services for testing the activity of potential cancer therapeutics
Tags: services
international
research
model
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||